This post was originally published on this site
Henry Schein announced earnings per share of $1.03 on revenue of $2.84B. Analysts polled by Investing.com anticipated EPS of $0.77 on revenue of $2.46B.
Henry Schein shares are down 4% from the beginning of the year, still down 14.07% from its 52 week high of $73.99 set on February 19. They are under-performing the S&P 500 which is up 1.21% from the start of the year.
Henry Schein’s report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on October 27 with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.71 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
